- Open Access
Expression of insulin-like 3 (INSL3) and differential splicing of its receptor in the ovary of rhesus macaques
Reproductive Biology and Endocrinology volume 8, Article number: 150 (2010)
Although insulin-like 3 (INSL3) has been identified in the gonad of both sexes in many species, there are only limited reports on the distribution of INSL3 and its receptor, relaxin/insulin-like family peptide receptor 2 (RXFP2), in the primate ovary. Since the hormone-receptor pair is believed to play a role in female reproduction, investigating the transcription of INSL3/RXFP2 genes and the spatiotemporal expression of INSL3 in the nonhuman primate may shed light on the functional aspects of the system in humans.
Database mining, molecular and immunological methods were applied.
One single INSL3 transcript and three novel splice variant transcripts of RXFP2 were identified in the ovary of rhesus macaques. While the full-length RXFP2 transcript is barely detectable in granulosa cells during the periovulatory period, INSL3 transcript and protein are highly abundant in theca cells surrounding antral follicles. Moreover, the INSL3 level in follicular fluid is 3-4 times higher than that in female serum which remains low throughout the menstrual cycle.
The presence of INSL3 and its receptor in the ovary implies a potential role of the ligand-receptor pair in female reproduction in nonhuman primates. However, the existence of multiple splice variants of RXFP2 indicates a very complex nature of the hormone-receptor system.
Insulin-like 3 (INSL3), also known as Leydig cell insulin-like peptide (Ley-IL) and relaxin-like factor (RLF), was originally discovered in the porcine during a search for testis-specific genes . Closely related to relaxin, INSL3 peptide is a heterodimer of A and B peptides linked by disulphide bonds. In mice, deletion of INSL3 leads to bilateral intra-abdominal cryptorchidism in males due to defects in gubernacular differentiation, and reduced fertility in females due to disrupted estrous cycles . Later studies also revealed that INSL3 promoted oocyte maturation independent of the mid-cycle luteinizing hormone (LH) surge in the ovary, and suppressed germ cell apoptosis in the testis in rodents . Relaxin/insulin-like family peptide receptor 2 (RXFP2), also known as Leucine-rich G protein-coupled receptor 8 (LGR8) or G protein-coupled receptor affecting testis descent (GREAT), is believed to be the sole receptor for INSL3 as mice lacking RXFP2 exhibit the same testicular phenotype as that of Insl3 knockout mice [4, 5]. Although decreased blood INSL3 levels and mutations in Insl3/RXFP2 genes have been linked to a small number of human cryptorchidism cases [6–10], functions of the INSL3-RXFP2 system in species other than mice are largely unknown.
Expression of the INSL3-RXFP2 system has been detected in many mammalian species including rodents, domestic and wild animals as well as primates [11–17]. The relatively high circulating INSL3 levels in male rodents and men indicate a substantial role of INSL3 as a sex-linked endocrine factor; however, the serum INSL3 levels in females are much lower .
In the present study we report the identification and expression of the INSL3-RXFP2 system in a nonhuman primate species, the rhesus macaque. Taking molecular and immunological approaches, we identified the macaque INSL3 and RXFP2 transcripts and splice variants in the ovary of rhesus monkeys, and investigated the tissue and cellular localization of INSL3 at both mRNA and protein levels. Due to the close resemblance of reproductive physiology between macaque species and humans, these findings may provide insights into the functional significance of the INSL3-RXFP2 signalling pathway in human female fertility.
Animals and tissue collection
Macaque tissues were collected from adult rhesus monkeys between 5 and 15 years of age through a tissue distribution program provided by the Division of Animal Resources (DAR) at the Oregon National Primate Research Center (ONPRC). All animal protocols and procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Oregon Health & Science University (OHSU) and were conducted in accordance with the National Institute of Health's Guide for the Care and Use of Laboratory Animals.
Database mining, 5'-rapid amplification of cDNA ends (5'-RACE) and amplification of RXFP2 splice variants
Human INSL3 mRNA sequence (NM_005543) was used to search a rhesus macaque genome database  and a non-human, non-mouse expressed sequence tag (EST) database  for the macaque INSL3 homologue, and gene-specific primers (Table 1) were designed to amplify the entire INSL3 mRNA sequence from a monkey testis cDNA pool. Using a predicted macaque RXFP2 mRNA sequence (XM_001118169.1) as template, we designed a specific primer (Table 1) to amplify the 5'-end of RXFP2 from the macaque uterus. 5'-RACE-ready cDNA was generated following the protocol provided by the SMART RACE cDNA Amplification Kit (Clontech, Moutain View, CA, USA). The exon-intron boundaries in macaque RXFP2 mRNA were determined by alignment with the human RXFP2 mRNA sequence using Vector NTI software (Invitrogen, Carlsbad, CA, USA).
Macaque RXFP2- specific primers (Table 1) spanning exons 6 to 17 were designed to amplify macaque RXFP2 coding sequence from macaque uterus and ovary RACE-ready cDNA pools. PCR was performed for 40 cycles with Phusion high-fidelity DNA polymerase (New England Biolabs Inc., Ipswich, MA, USA) in a DNA Engine thermal cycler (Bio-Rad Laboratories, Hercules, CA, USA). The PCR amplicons were cloned into the PCR cloning vector pGEMT (Promega, Madison, WI, USA) and subjected to DNA sequencing.
Collection of macaque oocytes, granulosa cells, and theca cells
For oocyte and granulosa cell collection, the controlled ovarian stimulation (COS) protocol, follicular aspiration, and oocyte collection procedures were performed as previously reported [21, 22]. Human chorionic gonadotropin (hCG) was administered as a LH mimic to initiate periovulatory events. Aspirated follicular fluid containing granulosa cells (GC) were filtered through a 70-μm cell strainer (Becton Dickinson Labware, Franklin Lakes, NJ, USA) and precipitated at low speed. GC were recovered through low-speed centrifugation in 40% percoll/Hanks balanced salt solution (HBSS) (Invitrogen). GC obtained from antral follicles prior to hCG treatment were considered non-luteinized GC (NLGC), while those collected after hCG administration were considered luteinized GC (LGC). Theca cells were collected from frozen monkey ovarian sections using a PixCell II (Arcturus, Sunnyvale, CA, USA) laser capture microdissection system following the manufacturer's protocol.
RNA isolation, RT-PCR, and in situ hybridization
Total RNA was extracted from monkey tissues and granulosa cells using Trizol reagent (Invitrogen), and from monkey oocytes and laser captured theca cells using Absolutely RNA Nanoprep Kit (Stratagene, La Jolla, CA, USA) following the recommended manufacturers' protocols. The integrity of total RNA was assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Santa Clara, CA, USA). Total RNA was then treated with RNase-free DNase (Promega, Madison, WI, USA) and reverse-transcribed into cDNA with Oligo (dT)12-18 primers and Superscript III Reverse Transcriptase (Invitrogen). RT-PCR primer pairs and corresponding annealing temperatures are listed in Table 1. PCR was performed with HotstarTaq DNA polymerase (Qiagen, Valencia, CA, USA) and all PCR products were verified by DNA sequencing. PPIA (PeptidylProlyl Isomerase A, also known as cyclophilin A) served as an internal control.
Selected macaque INSL3 and RXFP2 amplicons obtained by RT-PCR were cloned into the pGEMT vector (Promega). Monkey ovaries and testes were fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned at 5-μm intervals. α-35S-UTP-labeled antisense and sense probes were generated by the Riboprobe T7/SP6 combination systems (Promega). Hybridization was carried out as previously described [23, 24]. The paraffin sections hybridized with α-35S-UTP-labeled sense probe were used as a negative control.
Protein extraction and Western blot
Macaque tissue total protein was extracted using 1× RIPA buffer (50 mM Tris-HCl pH7.4, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.1% SDS) containing 1× Complete Protease Inhibitor Cocktail (Roche, Basel, Switzerland). Eighty μg of total protein in 1× Laemmli sample buffer (Bio-Rad Laboratories) was heated at 85°C for 5 minutes and then cooled to room temperature before being separated on a precast 4-20% polyacrylamide Tris-HCl gel (Bio-Rad Laboratories). The protein was transferred onto a PVDF membrane (Millipore, Billerica, MA, USA). The membrane with immobilized protein was blocked with StartingBlock T20 (TBS) Blocking Buffer (Pierce, Rockford, IL, USA) first, and then blotted with a rabbit anti-INSL3 antibody (ab65981, Abcam, Cambridge, MA, USA) at a 1:1,000 dilution. HRP-conjugated anti-rabbit IgG (Santa Cruz Biotechnology) was used as secondary antibody at a 1:10,000 dilution. Following a 5-minute incubation with ECL Western blotting substrate (Millipore), the signal was visualized on a Kodak Biomax light film (Kodak, Tokyo, Japan). The size of the detected protein band was determined by the PageRuler™ Plus Prestained Protein Ladder (Fermantas International Inc., Burlington, Ontario, Canada) separated on the same gel. The same membrane was stripped and re-blotted with HRP-conjugated mouse monoclonal beta-ACTIN (ab20272, Abcam) antibody (1:8,000 dilution), which served as an internal loading control.
Macaque ovary paraffin sections at 5-μm thickness were used for IHC. Before incubating with a rabbit anti-INSL3 antibody (H-035-48, Phoenix Pharmaceuticals, Burlingame, CA) which recognizes INSL3 precursor, the ovarian sections were deparaffinised, hydrated, and blocked with a universal blocking reagent named CAS BLOCK™(Invitrogen). IHC was performed with EnVision™dual link HRP (DAB+) kit (Dako, Carpinteria, CA, USA) according to the manufacturer's manual. The INSL3 antibody was diluted at 1:2,000, and the sections were counterstained with hematoxylin. Normal rabbit serum-stained sections were used as a negative control.
Individual macaque blood and follicular fluid samples were collected from 3-4 different monkeys and measured separately for INSL3 level with an INSL3 (human)-RIA kit (Phoenix Pharmaceuticals) following the manufacturer's protocol. The kit has a standard range of 10-1280 pg/ml with a minimum detectable range of 20.17 pg/ml. The intra- and inter-assay coefficient of variation is 5-7% and 12-15%, respectively. Female serum at follicular phase was collected from day 1 to day 14 of the menstrual cycle, while luteal phase serum was collected from day 15 to day 28 of the cycle. Follicular fluid was collected from preovulatory follicles during COS protocols . Follicular aspiration was performed in animals at day 8 of COS protocols prior to hCG treatment (0 h) and at 36 hrs post hCG (36 h). The values are presented as mean ± SE (standard error).
All experiments described above were replicated at least three times with biological samples derived from different animals. Tissues and cells collected from each animal were assayed individually.
Identification of INSL3 and RXFP2 transcripts in rhesus macaques
A full-length macaque INSL3 mRNA sequence without the poly(A) tail was amplified from the monkey testis cDNA pool and deposited in the GenBank database  with accession number HM102325. The macaque INSL3 homologue comprises 2 exons and shares ~93% identity with its human counterpart at the nucleotide level. The deduced macaque INSL3 precursor protein is composed of 131 amino acids which are ~90% identical with that in human INSL3 (NP_005534.2).
The 5'-end of macaque RXFP2 mRNA was amplified by 5'-RACE with cDNA derived from the macaque uterus (GU326354), and the protein deduced from RXFP2 coding region shares 96% identity with human RXFP2 protein (NP_570718.1). Macaque RXFP2 mRNA consists of 18 exons. To demonstrate whether RXFP2 splice variants exist in female reproductive system of rhesus macaques, we amplified exons 6 to 17 in the ovary and uterus by RT-PCR (Figure 1a). To our surprise, besides the full-length transcript at ~1.1 kb, three distinctive splice variants were also amplified from both tissues: RXFP2-sv1 is 877 bp long with exon 15 missing; RXFP2-sv2 is 808 bp and lacks both exons 11 and 15; and the shortest splice variant, RXFP2-sv3 (738 bp), has deleted exons 8, 11 and 15 (Figure 1b). The GenBank accession numbers for three spliced transcripts are GU326355, GU326356 and GU326357, respectively.
Distribution of INSL3-RXFP2 transcripts in rhesus macaques
Macaque INSL3-specific primers spanning both exons were used to amplify INSL3 transcripts from 14 macaque tissues. A cDNA fragment corresponding to 94-482 bp of macaque INSL3 mRNA was detectable mainly in the hypothalamus, ovary, pituitary and testis, with relatively higher abundance in the ovary and testis (Figure 2a). Macaque RXFP2-specific primers were designed to amplify the RXFP2 mRNA sequence between exons 11 and 15 so that only full-length transcript would be amplified. The full-length RXFP2 mRNA appears to be mainly expressed in the ovary and uterus, and weakly detectable in the hypothalamus and several other somatic tissues (Figure 2a).
The transcription of INSL3-RXFP2 was also examined in different cell populations in the ovary by RT-PCR (Figure 2b). Whereas INSL3 transcript was only detected in theca cells but not in the oocyte and granulosa cells, RXFP2 is expressed only in granulosa cells including both nonluteinized (NLGC) and luteinized granulosa cells (LGC). The experiment was repeated with oocytes of various stages (e.g., germinal vesicle intact, metaphase I and metaphase II) and ovarian somatic cells derived from multiple animals, and the full-length RXFP2 transcript was never amplified from either oocytes or thecal cells.
Consistent with the RT-PCR result, in situ hybridization detected abundant expression of INSL3 mRNA in the theca layers surrounding antral follicles, but not those surrounding secondary follicles (Figure 2c). Weak signals were also visible in corpora lutea. No signal above background was observed in either oocytes or granulosa cells. Despite RT-PCR amplification in the ovary, no specific RXFP2 signal was detected by in situ hybridization with multiple probes targeting different regions of RXFP2 mRNA, possibly due to a very low level expression of RXFP2 transcript in individual cells.
Expression of INSL3 protein in the macaque ovary
Using an antibody raised against human INSL3 precursor, an approximately 14.5 kDa band was detected in the macaque ovary, testis and pituitary (Figure 3a). The size of macaque INSL3 is identical to that of mouse (not shown). IHC detected specific staining of INSL3 antibody only in the theca layers surrounding antral follicles in the ovary (Figure 3b). Since only part of each macaque tissue was used for protein extraction and Western blot, quantitative analysis of the Western blot was not performed due to the uneven distribution of INSL3-expressing follicles in the ovary.
Measurement of INSL3 levels in serum and follicular fluid in macaques
Using a highly sensitive RIA kit, we measured the INSL3 levels in adult female monkey sera during natural menstrual cycles and in follicular fluid collected during COS protocols . The levels of INSL3 in the serum and follicular fluid are shown in Figure 3c. Throughout the entire menstrual cycle, there is no dramatic fluctuation of INSL3 levels in the female serum. On average, the serum INSL3 level in females (120.26 ± 7.37 pg/ml) is less than 1/3 of that in males (435.3 ± 125.6 pg/ml). However, INSL3 levels are substantially higher in the follicular fluid during the preovulatory period: 1027.78 ± 55.0 pg/ml prior to hCG treatment (0 h) and 592.59 ± 54.56 pg/ml prior to ovulation (36 h post hCG).
Nonhuman primates exhibit reproductive physiology that is similar to humans. For example, female rhesus macaques have 28-day mono-ovular menstrual cycles that closely resemble women's reproductive cycles, and utilize the LH-chorionic gonadotropin (CG) endocrine system unique to higher primates and absent in lower primates and nonprimates . Thus, nonhuman primates are the most relevant models for studies of human reproduction. Previous studies have shown that INSL3 is more likely to have a functional endocrine role in males than in females as the blood level of INSL3 in males is significantly higher than that in females . Our data demonstrates that INSL3 is also relatively enriched in the ovary of macaques, and the transcript of its full-length receptor can be detected in the ovary. The localization of the ligand to the theca layer and receptor to the granulosa cells suggests a potential local regulatory (paracrine) role of INSL3 in follicle maturation in nonhuman primates.
The structure and expression of INSL3-RXFP2 have been studied in primates in a limited manner. Previously an alternative splicing of INSL3, which possesses an extra exon (exon 1A) between exons 1 and 2, has been reported in marmoset monkeys  and humans (AY082014.1). Our data suggest that this particular splice variant of INSL3 does not exist in rhesus macaques for the primers spanning both exons consistently amplified one single transcript from different tissues derived from several monkeys. INSL3 mRNA has been detected in various mammalian tissues, mostly only by highly sensitive RT-PCR. In the marmoset monkey, INSL3 transcript was only identified in the testis by Northern blot and the ovarian corpora lutea by RT-PCR . Besides the ovary and testis, we also detected INSL3 mRNA in the hypothalamus and pituitary in the macaque. The hypothalamic expression of INSL3 transcript is consistent with a previous report in the cow, but has not been observed in rodents . However, an antibody recognizing INSL3 precursor failed to detect the protein in the hypothalamus despite evident INSL3 expression in the gonad and pituitary, suggesting a low-level or perhaps even no translation in this tissue. A recent report in rats demonstrated that Leydig cells in the testis could be the only source of circulating INSL3 . It remains to be elucidated whether INSL3 produced in the pituitary contributes to circulating INSL3 in the rhesus macaque. It is noteworthy that the relative intensities of INSL3 bands in the Western blot described in the current study do not represent the relative abundance of INSL3 in each tissue analyzed, because the selective cell types expressing INSL3 may not distribute evenly throughout the entire tissue (e.g., theca cells surrounding antral follicles in the ovary) and only part of each macaque tissue was used for protein extraction. No specific antibodies against monkey INSL3 were available, so we tested several anti-human INSL3 antibodies and eventually selected two different antibodies for their optimal performance in Western blot and IHC. Human INSL3 shares ~90% and ~60% identical amino acids with macaque and mouse INSL3, respectively. The antibody used for Western blot was raised against a short human INSL3 peptide that only differs in 2 amino acids from mouse INSL3 precursor; thus, it is not surprising that the antibody reacts with both monkey and mouse INSL3.
Full-length macaque RXFP2 is transcribed in several tissues including the hypothalamus, ovary and uterus. A previous study showed that RXFP2 was expressed in the testis but not in the ovary in humans . The contradiction could be, at least in part, attributed to the selection of primers, i.e., while only full-length RXFP2 transcript was amplified by primers spanning between exons 11 and 15 in our experiment, the amplification of 3'-UTR region of human RXFP2 would include various spliced transcripts. Indeed, the identification of three RXFP2 splice variants was previously reported in the human uterus and adrenal glands , although only one of the sequences, namely LGR8.1 which lacks exon 11 of RXFP2, can be found in the GenBank (AY899851.1). None of the three splice variants identified from the macaque corresponds exactly to LGR8.1, although two of them (i.e., RXFP2-sv2 and RXFP2-sv3) are missing exon 11. We noticed that the primers used to amplify LGR8.1 span exons 7-13 of human RXFP2, which could explain why the primer pair failed to identify the missing exon 15 that was found in all three splice variants reported in the current study. Unlike LGR8.1 that can be translated into a truncated RXFP2 protein with partial leucine-rich repeat (LRR) region, translation of all three RXFP2 splice variants identified in the current study can cause early termination of the full-length open reading frame (ORF) prior to the seven-transmembrane (7TM) domain-coding region (Figure 1b).
Within the ovary, INSL3 transcript and peptide are predominantly expressed in the theca cells surrounding antral follicles and weakly detectable in the corpus luteum. This finding is similar to previous observations in the cow  as well as in two other primate species, marmoset monkeys and humans [16, 17]. INSL3 was originally demonstrated as a male hormone required for testis positioning during fetal development [2, 32, 33]. A previous finding showing that INSL3 was expressed in the ruminant ovary at a much higher level than other species was attributed to the natural loss of the gene for relaxin . Here we show that INSL3 is also highly expressed in the primate ovary, even though relaxin gene still exists in this species . The function of INSL3 in the female reproductive system has not been well characterized. Besides the potential anti-apoptotic role of INSL3 in the mouse ovary , Hsueh's group  reported that INSL3 could function as a local mediator for the mid-cycle LH surge and promote the oocyte meiotic resumption through binding to RXFP2, an inhibitory G (Gi) protein-coupled receptor (GPCR). Although some recent evidence shows that the oocyte maturation in response to LH may be independent of Gi proteins , the highly enriched local INSL3 and the presence of its receptor imply a possible local regulatory role of the ligand-receptor in the ovary, especially during preovulatory period. Notably, we did not detect RXFP2 transcript or protein in the germinal vesicle intact oocyte, so any effect of INSL3 on maturation must be mediated through the cumulus granulosa cells. More functional studies in higher species will be required to solve this puzzle. The failure of RXFP2 detection in the ovary could be due to very low-level expression of GPCRs in individual cells, the specificity of antibodies applied, and/or an unknown nature of RXFP2 gene transcription and translation. The presence of three differentially spliced transcripts of RXFP2 in the ovary, and the localization of full-length RXFP2 mRNA in granulosa cells has not been previously reported. The majority of primate genes produce splice variant transcripts ; it is impossible to predict whether these splice variants can actually be translated into proteins, whether these proteins are functional, or whether these alternatively spliced transcripts have a function independent of protein synthesis. However, since the reported splice variants of RXFP2 encode truncated protein isoforms without the seven-transmembrane domain, these protein products are unlikely to function as GPCRs even if they do exist [39, 40]. It also remains to be determined whether the cellular localization of full-length RXFP2 transcript in the ovary is specific to rhesus monkeys.
Taken together, we identified the INSL3-RXFP2 transcripts and determined the tissue and cellular distribution of INSL3 in the ovary of rhesus macaque monkeys. Despite the rapid increasing number of studies on this newly identified ligand-receptor pair, the expression and function of the system appear much more complex than originally thought, especially in more advanced species. Further biochemical and pharmacological studies in nonhuman primates may eventually reveal the roles of INSL3 and the significance of multiple splice variants of RXFP2 in the ovary.
Adham IM, Burkhardt E, Benahmed M, Engel W: Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J Biol Chem. 1993, 268 (35): 26668-26672.
Nef S, Parada LF: Cryptorchidism in mice mutant for Insl3. Nat Genet. 1999, 22 (3): 295-299. 10.1038/10364.
Kawamura K, Kumagai J, Sudo S, Chun SY, Pisarska M, Morita H, Toppari J, Fu P, Wade JD, Bathgate RA, Hsueh AJ: Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc Natl Acad Sci USA. 2004, 101 (19): 7323-7328. 10.1073/pnas.0307061101.
Bogatcheva NV, Truong A, Feng S, Engel W, Adham IM, Agoulnik AI: GREAT/LGR8 is the only receptor for insulin-like 3 peptide. Mol Endocrinol. 2003, 17 (12): 2639-2646. 10.1210/me.2003-0096.
Gorlov IP, Kamat A, Bogatcheva NV, Jones E, Lamb DJ, Truong A, Bishop CE, McElreavey K, Agoulnik AI: Mutations of the GREAT gene cause cryptorchidism. Hum Mol Genet. 2002, 11 (19): 2309-2318. 10.1093/hmg/11.19.2309.
Bay K, Hartung S, Ivell R, Schumacher M, Jurgensen D, Jorgensen N, Holm M, Skakkebaek NE, Andersson AM: Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. J Clin Endocrinol Metab. 2005, 90 (6): 3410-3418. 10.1210/jc.2004-2257.
Bogatcheva NV, Ferlin A, Feng S, Truong A, Gianesello L, Foresta C, Agoulnik AI: T222P mutation of the insulin-like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane. Am J Physiol Endocrinol Metab. 2007, 292 (1): E138-144. 10.1152/ajpendo.00228.2006.
El Houate B, Rouba H, Imken L, Sibai H, Chafik A, Boulouiz R, Chadli E, Hassar M, McElreavey K, Barakat A: No association between T222P/LGR8 mutation and cryptorchidism in the Moroccan population. Horm Res. 2008, 70 (4): 236-239. 10.1159/000151596.
Roh J, Virtanen H, Kumagai J, Sudo S, Kaleva M, Toppari J, Hsueh AJ: Lack of LGR8 gene mutation in Finnish patients with a family history of cryptorchidism. Reprod Biomed Online. 2003, 7 (4): 400-406. 10.1016/S1472-6483(10)61883-4.
Yamazawa K, Wada Y, Sasagawa I, Aoki K, Ueoka K, Ogata T: Mutation and polymorphism analyses of INSL3 and LGR8/GREAT in 62 Japanese patients with cryptorchidism. Horm Res. 2007, 67 (2): 73-76. 10.1159/000096089.
Hombach-Klonisch S, Schon J, Kehlen A, Blottner S, Klonisch T: Seasonal expression of INSL3 and Lgr8/Insl3 receptor transcripts indicates variable differentiation of Leydig cells in the roe deer testis. Biol Reprod. 2004, 71 (4): 1079-1087. 10.1095/biolreprod.103.024752.
Klonisch T, Steger K, Kehlen A, Allen WR, Froehlich C, Kauffold J, Bergmann M, Hombach-Klonisch S: INSL3 ligand-receptor system in the equine testis. Biol Reprod. 2003, 68 (6): 1975-1981. 10.1095/biolreprod.102.008466.
Boockfor FR, Fullbright G, Bullesbach EE, Schwabe C: Relaxin-like factor (RLF) serum concentrations and gubernaculum RLF receptor display in relation to pre- and neonatal development of rats. Reproduction. 2001, 122 (6): 899-906. 10.1530/rep.0.1220899.
Hombach-Klonisch S, Kauffold J, Rautenberg T, Steger K, Tetens F, Fischer B, Klonisch T: Relaxin-like factor (RLF) mRNA expression in the fallow deer. Mol Cell Endocrinol. 2000, 159 (1-2): 147-158. 10.1016/S0303-7207(99)00190-2.
Burkhardt E, Adham IM, Brosig B, Gastmann A, Mattei MG, Engel W: Structural organization of the porcine and human genes coding for a Leydig cell-specific insulin-like peptide (LEY I-L) and chromosomal localization of the human gene (INSL3). Genomics. 1994, 20 (1): 13-19. 10.1006/geno.1994.1121.
Bamberger AM, Ivell R, Balvers M, Kelp B, Bamberger CM, Riethdorf L, Loning T: Relaxin-like factor (RLF): a new specific marker for Leydig cells in the ovary. Int J Gynecol Pathol. 1999, 18 (2): 163-168. 10.1097/00004347-199904000-00011.
Zarreh-Hoshyari-Khah MR, Einspanier A, Ivell R: Differential splicing and expression of the relaxin-like factor gene in reproductive tissues of the marmoset monkey (Callithrix jacchus). Biol Reprod. 1999, 60 (2): 445-453. 10.1095/biolreprod60.2.445.
Ferlin A, Foresta C: Insulin-like factor 3: a novel circulating hormone of testicular origin in humans. Ann N Y Acad Sci. 2005, 1041: 497-505. 10.1196/annals.1282.074.
Baylor College of Medicine, Human Genome Sequencing Center. [http://blast.hgsc.bcm.tmc.edu/blast.hgsc?organism=7]
Basic Local Alignment Search Tool (BLAST). [http://blast.ncbi.nlm.nih.gov/Blast.cgi]
Stouffer RL, Zelinski-Wooten MB: Overriding follicle selection in controlled ovarian stimulation protocols: quality vs quantity. Reprod Biol Endocrinol. 2004, 2: 32-10.1186/1477-7827-2-32.
McDaniel P, Wu X: Identification of oocyte-selective NLRP genes in rhesus macaque monkeys (Macaca mulatta). Mol Reprod Dev. 2009, 76 (2): 151-159. 10.1002/mrd.20937.
Wu X, Chen L, Brown CA, Yan C, Matzuk MM: Interrelationship of growth differentiation factor 9 and inhibin in early folliculogenesis and ovarian tumorigenesis in mice. Mol Endocrinol. 2004, 18 (6): 1509-1519. 10.1210/me.2003-0399.
Wu X, Viveiros MM, Eppig JJ, Bai Y, Fitzpatrick SL, Matzuk MM: Zygote arrest 1 (Zar1) is a novel maternal-effect gene critical for the oocyte-to-embryo transition. Nat Genet. 2003, 33 (2): 187-191. 10.1038/ng1079.
Muller T, Gromoll J, Simoni M: Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action. J Clin Endocrinol Metab. 2003, 88 (5): 2242-2249. 10.1210/jc.2002-021946.
Foresta C, Bettella A, Vinanzi C, Dabrilli P, Meriggiola MC, Garolla A, Ferlin A: A novel circulating hormone of testis origin in humans. J Clin Endocrinol Metab. 2004, 89 (12): 5952-5958. 10.1210/jc.2004-0575.
Bathgate R, Balvers M, Hunt N, Ivell R: Relaxin-like factor gene is highly expressed in the bovine ovary of the cycle and pregnancy: sequence and messenger ribonucleic acid analysis. Biol Reprod. 1996, 55 (6): 1452-1457. 10.1095/biolreprod55.6.1452.
Anand-Ivell R, Heng K, Hafen B, Setchell B, Ivell R: Dynamics of INSL3 peptide expression in the rodent testis. Biol Reprod. 2009, 81 (3): 480-487. 10.1095/biolreprod.109.077552.
Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Bathgate RA, Sherwood OD, Hsueh AJ: Relaxin signaling in reproductive tissues. Mol Cell Endocrinol. 2003, 202 (1-2): 165-170.
Muda M, He C, Martini PG, Ferraro T, Layfield S, Taylor D, Chevrier C, Schweickhardt R, Kelton C, Ryan PL, Bathgate RA: Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity. Mol Hum Reprod. 2005, 11 (8): 591-600. 10.1093/molehr/gah205.
Adham IM, Agoulnik AI: Insulin-like 3 signalling in testicular descent. Int J Androl. 2004, 27 (5): 257-265. 10.1111/j.1365-2605.2004.00481.x.
Zimmermann S, Steding G, Emmen JM, Brinkmann AO, Nayernia K, Holstein AF, Engel W, Adham IM: Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol. 1999, 13 (5): 681-691. 10.1210/me.13.5.681.
Hartung S, Kondo S, N A, Hunt N, Rust W, Balvers M, Bryant-Greenwood G, Ivell R: The search for ruminant relaxin. Progress in Relaxin Research. Edited by: Maclennan A, Tregear GW, Bryant-Greenwood G. 1995, Singapore: World Scientific, 439-456.
Kawamura K, Sudo S, Kumagai J, Pisarska M, Hsu SY, Bathgate R, Wade J, Hsueh AJ: Relaxin research in the postgenomic era. Ann N Y Acad Sci. 2005, 1041: 1-7. 10.1196/annals.1282.001.
Spanel-Borowski K, Schafer I, Zimmermann S, Engel W, Adham IM: Increase in final stages of follicular atresia and premature decay of corpora lutea in Insl3-deficient mice. Mol Reprod Dev. 2001, 58 (3): 281-286. 10.1002/1098-2795(200103)58:3<281::AID-MRD6>3.0.CO;2-0.
Mehlmann LM, Kalinowski RR, Ross LF, Parlow AF, Hewlett EL, Jaffe LA: Meiotic resumption in response to luteinizing hormone is independent of a Gi family G protein or calcium in the mouse oocyte. Dev Biol. 2006, 299 (2): 345-355. 10.1016/j.ydbio.2006.07.039.
Skandalis A, Frampton M, Seger J, Richards MH: The adaptive significance of unproductive alternative splicing in primates. RNA. 16 (10): 2014-2022. 10.1261/rna.2127910.
Yona S, Lin HH, Siu WO, Gordon S, Stacey M: Adhesion-GPCRs: emerging roles for novel receptors. Trends Biochem Sci. 2008, 33 (10): 491-500. 10.1016/j.tibs.2008.07.005.
Rompler H, Staubert C, Thor D, Schulz A, Hofreiter M, Schoneberg T: G protein-coupled time travel: evolutionary aspects of GPCR research. Mol Interv. 2007, 7 (1): 17-25. 10.1124/mi.7.1.5.
The authors thank the following core facilities at Oregon National Primate Research Center: the Assistant Reproductive Technologies (ART) core for assisting in monkey oocyte collection; the Molecular and Cellular Biology (MCB) core for sequencing; and the Imaging and Morphology (IM) core for tissue processing and photographing. Drs John Wade of the University of Melbourne and Richard Ivell of the University of Adelaide provided helpful suggestions for the experiments. The research is supported by a U54 Specialized Cooperative Research Center grant (5U54HD055744) to Drs. Richard Stouffer and J.T.J. from the National Institute of Child Health and Human Development (NICHD). Dr. C.B.H. was a postdoctoral fellow supported by a Reproductive Biology training grant (5T32HD007133) to Dr. Judy Cameron. Dr. M.C. P. was a Fogarty fellow supported by grant TW/HD-00668 to P. Michael Conn.
The authors declare that they have no competing interests.
CBH carried out the identification of INSL3 and RXFP2 transcripts and splice variants, as well as PCR amplification of INSL3 from multiple macaque tissues. SY performed Western blot and IHC for INSL3. MCP participated in sample preparation and collection. JTJ conducted the measurement and analysis of INSL3 in the follicular fluid and blood. XW carried out INSL3 and RXFP2 sequence alignment, analysis, and manuscript preparation. All authors read and approved the final manuscript.